Cognitive Assessment by the Mean of Event Related Potentials

University Hospital, Limoges320 enrolled

Overview

The main objective of this study is to describe differential cognitive processing of various stimuli by a population of control subjects and a population of patients with selective cognitive deficits or altered states of consciousness by using dedicated ERP paradigms and high-density EEG picked up system.

In order to test the relevance of theoretical models of cognitive functions, examination of patients with cerebral lesions is of great interest. Thus, the goal of this study is to assess cognitive processing in patients by a combination of behavioural clinical tests and ERP (event related potentials) specific markers. Indeed, ERP technique makes it possible to ascertain that a patient or control subject has or has not performed the task we asked him to even if the subject performs the task covertly. From these ERPs markers, we can investigate their respective cortical generators. By comparing the results obtained in both healthy and pathological populations, we will be able to appreciate differential processing of the same stimuli by two different populations and try to correlate these differences with specific cerebral lesions and with different outcomes.We previously demonstrated the relevance of this approach in the field of disorders of consciousness patients and we project to enrich this specific approach by the addition of new markers and by its extension to other fields of cognitive and behavioural neurology. The procedure will be the following. After obtaining written informed consent, patients will be examined clinically with dedicated specialized scales (for example the CRS-R for disorders of consciousness patients). Then, we will probe event related potentials by stimulating these patients with various stimuli embedded in well-designed paradigms while their scalp EEG will be recorded. Following different steps of signal processing the mean ERPs according to conditions will be extracted and statistical analysis will be performed. At one year from the recording, outcome will be collected and correlated with the obtained ERPs.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

DIAGNOSTIC

Masking

NONE

Enrollment

320

Conditions

Brain Injuries

Interventions

Eligibility

Sex: ALLMin age: 18 YearsMax age: 80 YearsHealthy volunteers:

Medical Language ↔ Plain English

Control subjects Inclusion Criteria: * adults between 18 and 80, * written informed consent obtained from the subject, * covers by social insurance, * absence of psychoactive drug intake in the week preceding the examination or alcohol intake the day before the exam Exclusion Criteria: * pregnant patients or breastfeeding, * sensory deficit incompatible with the participation in tne study, * person under a legal protection measure, under guardianship, * psychoactive drug intake in the week preceding the examination or alcohol intake the day before the exam Patients : Inclusion Criteria: * adults between 18 and 80, * written informed consent obtained from the patient or his relatives, * covers by social insurance, * patients with either focal or diffuse brain damage drom trauma, vascular, tumor or other aetiologies, or with a history of neonatal or congenital diseases, * patients with selective cognitive disorders or with altered states of consciousness Exclusion Criteria: * Pregnant patients or breastfeeding, * sensory deficit incompatible with the participation in the study

Locations (1)

CHU of Limoges

Limoges, France

RECRUITING

Outcomes

Primary Outcomes

Cognitive processing assessment

Specific Event Related Potential (ERP) presence. ERP measurements indicate if a patient or control subject has or has not performed the task we asked him to even if the subject performs the task covertly

Time frame: Day1

Secondary Outcomes

Scalp topographies of ERPs

Links between the performance of a given task and the brain areas cognitive function.

Time frame: Day 1

Cognitive assessment by means of specialized scales

Patients will be examined clinically with dedicated specialized scales: CRS-R (Coma Recovery Scale- Revised), GOSE (Glasgow Outcome Scale Extended) and other dedicated scorings.

Time frame: Day1, Day 356

Central Contacts

Frederic Faugeras, Dr

CONTACT

05 55 05 65 65 frederic.faugeras@laposte.net

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.